NATHALIE ALLISON-FECTEAU: Open Payments
NPI 1841597572 · DELRAY BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$956 in 39 payments from 13 companies in 2025. Trend: 2023 $493 · 2024 $723 · 2025 $956
Food & beverage: $956
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 4 | $194 |
| UCB, Inc. | 7 | $175 |
| ABBVIE INC. | 10 | $162 |
| GENZYME CORPORATION | 4 | $141 |
| Novartis Pharmaceuticals Corporation | 3 | $71 |
| PFIZER INC. | 3 | $60 |
| Galderma Laboratories, L.P. | 2 | $32 |
| Amgen Inc. | 1 | $29 |
| Janssen Biotech, Inc. | 1 | $26 |
| LEO Pharma Inc. | 1 | $24 |
Products named: OPZELURA, Bimzelx, DUPIXENT, SKYRIZI, CIBINQO, COSENTYX, OTEZLA, TREMFYA.
Industry payments across FL — which companies pay providers there.
